These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35948957)

  • 1. Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease.
    Cao J; Hua L; Zhang S; Tang J; Ke F; Wu Z; Xue G
    Lipids Health Dis; 2022 Aug; 21(1):70. PubMed ID: 35948957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
    Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
    Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease.
    Ke F; Xue G; Jiang X; Li F; Lai X; Zhang M; Shen Y; Gao L
    Cytokine; 2020 Oct; 134():155184. PubMed ID: 32645536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity.
    Wang R; Yang F; Qing L; Huang R; Liu Q; Li X
    Clin Obes; 2019 Feb; 9(1):e12289. PubMed ID: 30411515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.
    Bhatt SP; Misra A; Nigam P; Guleria R; Pasha MA
    PLoS One; 2015; 10(11):e0142260. PubMed ID: 26599361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD).
    Darmadi D; Ruslie RH
    Rom J Intern Med; 2021 Mar; 59(1):66-72. PubMed ID: 33055315
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease.
    Wen Y; Zhang H; Yang N; Gao X; Chen Z; Liu J; Wang G
    Front Endocrinol (Lausanne); 2023; 14():1173826. PubMed ID: 37600722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.
    Kumar R; Prakash S; Chhabra S; Singla V; Madan K; Gupta SD; Panda SK; Khanal S; Acharya SK
    Indian J Med Res; 2012 Aug; 136(2):229-36. PubMed ID: 22960889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
    Shipovskaya AA; Dudanova OP; Kurbatova IV
    Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.
    Zhu JZ; Zhu HT; Dai YN; Li CX; Fang ZY; Zhao DJ; Wan XY; Wang YM; Wang F; Yu CH; Li YM
    Endocrine; 2016 Jan; 51(1):91-100. PubMed ID: 26362060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
    Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance.
    Toonen EJ; Mirea AM; Tack CJ; Stienstra R; Ballak DB; van Diepen JA; Hijmans A; Chavakis T; Dokter WH; Pham CT; Netea MG; Dinarello CA; Joosten LA
    Mol Med; 2016 May; 22():202-14. PubMed ID: 27261776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].
    Chellali S; Boudiba A; Griene L; Koceir EA
    Ann Biol Clin (Paris); 2019 Jun; 77(3):261-271. PubMed ID: 30998190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.